VALNEVA (EPA:VLA) | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
VALNEVA

BRIEF

published on 04/12/2024 at 10:42, 7 months 9 days ago

Upbeat Valneva Research Update from First Berlin Equity Research Maintains BUY Rating

First Berlin Equity Research Buy Recommendation Financial Strategy Valneva Lyme Disease Vaccine
PRESS RELEASE

published on 04/12/2024 at 10:37, 7 months 9 days ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating on Valneva with a target price of €8.60, following positive guidance revisions and debt extension

First Berlin Equity Research BUY Rating Debt Extension Valneva EUR 8.60
PRESS RELEASE

published on 02/27/2024 at 16:01, 8 months 22 days ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH updates Valneva SE research report, reiterating Buy recommendation with a target price of €8.60 based on strong FY/23 product revenue recovery and positive outlook for travel vaccines and future prospects

Buy Recommendation Research Update Target Price Valneva SE Product Revenue
BRIEF

published on 02/27/2024 at 16:01, 8 months 22 days ago

First Berlin updates its recommendation on Valneva with an adjusted price target

First Berlin Equity Research Purchase Recommendation Valneva Simon Scholes Course Objective
PRESS RELEASE

published on 10/12/2023 at 10:11, 1 year 1 month ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 05/22/2023 at 13:41, 1 year 5 months ago

Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 04/04/2023 at 15:46, 1 year 7 months ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy

Accesswire

Published on 11/21/2024 at 14:15, 12 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 27 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 27 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 27 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 27 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 11 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 12 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 27 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 12 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 52 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 29 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 7 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 42 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 42 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE